Fetal metabolic programming and epigenetic modifications: A systems biology approach

Pediatric Research

Volumn 73, Issue 4-2, 2013, Pages 531-542

  Sookoian, Silvia ^a   Gianotti, Tomas Fernández ^a   Burgueño, Adriana L ^a   Pirola, Carlos J ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE;

DNA METHYLATION; EPIGENETICS; FETUS DEVELOPMENT; GENE EXPRESSION; GLUCOSE METABOLISM; HISTONE MODIFICATION; LIPID METABOLISM; PRENATAL GROWTH; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMS BIOLOGY;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; EPIGENOMICS; FATTY LIVER; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; GLUCOSE; HUMANS; HYPOTHALAMUS; INSULIN RESISTANCE; LIPIDS; LIVER; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METABOLIC SYNDROME X; PREGNANCY; SYSTEMS BIOLOGY;

EID: 84877349202     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.2     Document Type: Review

References (49)

1. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 1996;94:3246-50.
2. Harder T, Rodekamp E, Schellong K, Dudenhausen J W, Plagemann A. Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 2007;165:849-57.
3. Osmond C, Barker DJ, Winter PD, Fall CH, Simmonds SJ. Early growth and death from cardiovascular disease in women. BMJ 1993;307: 1519-24.
4. Forsén T, Eriksson JG, Tuomilehto J, Osmond C, Barker DJ. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ 1999;319:1403-7.
5. Barker DJ, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ 1990;301:259-62.
6. Poston L. Gestational weight gain: infuences on the long-term health of the child. Curr Opin Clin Nutr Metab Care 2012;15:252-7.
7. Hales CN, Barker DJ. The thrify phenotype hypothesis. Br Med Bull 2001;60:5-20.
8. Barker DJ. A new model for the origins of chronic disease. Med Health Care Philos 2001;4:31-5.
9. Barbosa-Silva A, Fontaine J F, Donnard ER, Stussi F, Ortega JM, Andrade-Navarro MA. PESCADOR, a web-based tool to assist text-mining of biointeractions extracted from PubMed queries. BMC Bioinformatics 2011;12:435.
10. You JS, Kelly TK, De Carvalho DD, Taberlay PC, Liang G, Jones PA. OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proc Natl Acad Sci USA 2011;108:14497-502.
11. Warde-Farley D, Donaldson SL, Comes O, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010;38(Web Server issue):W214-20.
12. Burgueño AL, Gianotti TF, Mansilla NG, Pirola CJ, Sookoian S. Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1a in a rat model. Clin Sci 2013;124:53-63.
13. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008; 49:600-7.
14. Burgueño AL, Cabrerizo R, Gonzales Mansilla N, Sookoian S, Pirola CJ. Maternal high-fat intake during pregnancy programs metabolic-syndrome- related phenotypes through liver mitochondrial DNA copy number and transcriptional activity of liver PPARGC1A. J Nutr Biochem 2013;24:6-13.
15. George LA, Zhang L, Tuersunjiang N, et al. Early maternal undernutrition programs increased feed intake, altered glucose metabolism and insulin secretion, and liver function in aged female ofspring. Am J Physiol Regul Integr Comp Physiol 2012;302:R795-804.
16. Camm EJ, Martin-Gronert MS, Wright NL, Hansell JA, Ozanne SE, Giussani DA. Prenatal hypoxia independent of undernutrition promotes molecular markers of insulin resistance in adult ofspring. FASEB J 2011; 25:420-7.
17. Begum G, Stevens A, Smith EB, et al. Epigenetic changes in fetal hypotha-lamic energy regulating pathways are associated with maternal undernutri-tion and twinning. FASEB J 2012;26:1694-703.
18. Chen H, Simar D, Lambert K, Mercier J, Morris MJ. Maternal and postnatal overnutrition diferentially impact appetite regulators and fuel metabolism. Endocrinology 2008;149:5348-56.
19. Bouret SG. Leptin, nutrition, and the programming of hypothalamic feeding circuits. Nestle Nutr Workshop Ser Pediatr Program 2010;65:25-35; discussion 35-9.
20. Gemma C, Sookoian S, Alvariñas J, et al. Mitochondrial DNA depletion in small-and large-for-gestational-age newborns. Obesity (Silver Spring) 2006;14:2193-9.
21. Carabelli J, Burgueño AL, Rosselli MS, et al. High fat diet-induced liver ste-atosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia. J Cell Mol Med 2011;15:1329-38.
22. Sookoian S, Castaño GO, Burgueño AL, Gianotti TF, Rosselli MS, Pirola CJ. The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease. Pharmacogenet Genomics 2010;20:1-8.
23. Sookoian S, Castaño G, Gianotti TF, Gemma C, Rosselli MS, Pirola CJ. Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease. Cytokine 2008;44:201-6.
24. Rosselli MS, Burgueño AL, Carabelli J, Schuman M, Pirola CJ, Sookoian S. Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. Atherosclerosis 2009;206:119-26.
25. Sookoian S, Rosselli MS, Gemma C, et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. Hepatology 2010;52:1992-2000.
26. Pirola CJ, Fernández Gianotti T, Burgueño AL, et al. Epigenetic modifcation of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 2012; e-pub ahead of print 9 August 2012.
27. Sookoian S, Gemma C, Pirola CJ. Infuence of hepatocyte nuclear factor 4alpha (HNF4alpha) gene variants on the risk of type 2 diabetes: a meta-analysis in 49, 577 individuals. Mol Genet Metab 2010;99:80-9.
28. Dallmann R, Weaver DR. Altered body mass regulation in male mPeriod mutant mice on high-fat diet. Chronobiol Int 2010;27:1317-28.
29. Sookoian S, Castaño G, Gemma C, Gianotti TF, Pirola CJ. Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease. World J Gastroenterol 2007;13:4242-8.
30. Sookoian S, Gemma C, Gianotti TF, Burgueño A, Castaño G, Pirola CJ. Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr 2008;87:1606-15.
31. Turek F W, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005;308:1043-5.
32. García SI, Pirola CJ. Tyrotropin-releasing hormone in cardiovascular pathophysiology. Regul Pept 2005;128:239-46.
33. Landa MS, García SI, Schuman ML, et al. Knocking down the dience-phalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat. Am J Physiol Endocrinol Metab 2007;292:E1388-94.
34. García SI, Porto PI, Dieuzeide G, et al. Tyrotropin-releasing hormone receptor (TRHR) gene is associated with essential hypertension. Hypertension 2001;38(3 Pt 2):683-7.
35. Vacher CM, Crépin D, Aubourg A, et al. A putative physiological role of hypothalamic CNTF in the control of energy homeostasis. FEBS Lett 2008;582:3832-8.
36. Liu QS, Wang QJ, Du GH, et al. Recombinant human ciliary neurotrophic factor reduces weight partly by regulating nuclear respiratory factor 1 and mitochondrial transcription factor A. Eur J Pharmacol 2007;563: 77-82.
37. Gemma C, Sookoian S, Dieuzeide G, et al. Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents. Mol Genet Metab 2010;100:83-7.
38. Gianotti T F, Sookoian S, Dieuzeide G, et al. A decreased mitochondrial DNA content is related to insulin resistance in adolescents. Obesity (Silver Spring) 2008;16:1591-5.
39. Burgueño AL, Carabelli J, Sookoian S, Pirola CJ. The impact of maternal high-fat feeding on liver and abdominal fat accumulation in adult ofspring under a long-term high-fat diet. Hepatology 2010;51:2234-5.
40. Gemma C, Sookoian S, Alvariñas J, et al. Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity (Silver Spring) 2009;17:1032-9.
41. Perkins E, Murphy SK, Murtha A P, et al. Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children. J Pedi-atr 2012;161:31-9.
42. Godfrey KM, Sheppard A, Gluckman PD, et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 2011;60:1528-34.
43. Ferland-McCollough D, Fernandez-Twinn DS, Cannell IG, et al. Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes. Cell Death Difer 2012;19:1003-12.
44. Maccani MA, Padbury JF, Marsit CJ. miR-16 and miR-21 expression in the placenta is associated with fetal growth. PLoS ONE 2011;6:e21210.
45. Yan X, Huang Y, Zhao JX, et al. Maternal obesity downregulates microRNA let-7g expression, a possible mechanism for enhanced adipogenesis during ovine fetal skeletal muscle development. Int J Obes (Lond) 2012; e-pub ahead of print 22 May 2012.
46. Genovese G, Ergun A, Shukla SA, et al. microRNA regulatory network inference identifes miR-34a as a novel regulator of TGF-ß signaling in glioblastoma. Cancer Discov 2012;2:736-49.
47. Yamakuchi M. MicroRNA Regulation of SIRT1. Front Physiol 2012; 3:68.
48. Rebholz-Schuhmann D, Oellrich A, Hoehndorf R. Text-mining solutions for biomedical research: enabling integrative biology. Nat Rev Genet 2012;13:829-39.
49. Hooper SD, Bork P. Medusa: a simple tool for interaction graph analysis. Bioinformatics 2005;21:4432-3.